MAGNOLIA CAPITAL ADVISORS LLC

Position in ACHV — Achieve Life Sciences, Inc.

CIK 1803662 RIDGELAND, MS

Position in ACHV

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$70,854

+$6,990 QoQ

Shares Held

24,100

+87.5% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#46

of 81 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

MAGNOLIA CAPITAL ADVISORS LLC holds $1,183,731 across 5 Biotechnology names. ACHV ranks #4 (6.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DMAC	DiaMedica Therapeutics Inc.	77,405	$524,031
2	VKTX	Viking Therapeutics, Inc.	12,115	$394,222
3	PGEN	Precigen, Inc.	36,531	$141,374
4	ACHV	Achieve Life Sciences, Inc. This page	24,100	$70,854
5	CGEN	Compugen Ltd	25,000	$53,250

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$70,854	24,100	+87.5%	Shares	Sole	2026-05-15
2025-12-31	$63,864	12,850	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.